Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 1Teratoma 1Sarcoma 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1HIV Infections 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Vincristine 9Cyclophosphamide 8Cisplatin 7Radiotherapy 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Radiation 4Lomustine 4Filgrastim 4Etoposide 4Carboplatin 4Magnetic Resonance Spectroscopy 3Irinotecan 3Granulocyte Colony-Stimulating Factor 3sodium thiosulfate 2merphos 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Methotrexate 2sonidegib 1silmitasertib 1sargramostim 1ribociclib 1palbociclib 1omburtamab I-131 1lonafarnib 1laromustine 1emvododstat 1azurin (50-77) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Medulloblastoma × Restraint, Physical × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡